Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BayStar Capital Management was a prominent investment firm based in the San Francisco Bay Area, specializing in Private Investment in Public Equity (PIPE) transactions. Founded by Lawrence Goldfarb in 1998, the firm became a significant financier for small-cap and mid-cap companies, with a heavy emphasis on the biotechnology, life sciences, and technology sectors. During the early 2000s, BayStar provided essential growth capital to numerous biotech firms, supporting their clinical development and commercialization efforts. The firm gained notoriety for its involvement in high-profile deals and subsequent legal disputes, including its investment in the SCO Group. Following regulatory challenges and a settlement with the SEC in 2012, the firm ceased its primary investment operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BayStar Capital.